Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.6.4) indicating a recent update to the ClinicalTrials.gov record. No study details or terms appear to be changed in the visible context.
    Difference
    0.1%
    Check dated 2026-07-27T05:53:58.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing Revision: v3.6.2. This indicates the page has been updated to a newer revision.
    Difference
    0.1%
    Check dated 2026-07-05T14:34:41.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend or template update. This update does not modify the study content or user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-06-28T08:45:34.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment heading; the old Intervention / Treatment label and the previous Revision note (Revision: v3.5.5) were removed, aligning with the new v3.6.0 revision.
    Difference
    0.5%
    Check dated 2026-06-13T18:05:52.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision label on the page changes from v3.5.4 to v3.5.5. This reflects a metadata/version update and does not alter the visible content.
    Difference
    0.1%
    Check dated 2026-06-06T14:11:51.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    A new revision label (v3.5.4) replaces the previous v3.5.3, indicating a backend or display update without changing the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-05-15T23:49:33.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.